Estrogen News and Research

Latest Estrogen News and Research

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause

Secondary analyses of findings from the Women's Health Initiative (WHI) suggest that women who begin hormone therapy within 10 years of menopause may have less risk of coronary heart disease (CHD) due to hormone therapy than women farther from menopause.

3 Apr 2007

Chemotherapy and tamoxifen combination improves survival for early-stage breast cancer patients

Patients with early-stage breast cancer who are treated with both chemotherapy and tamoxifen have a higher survival rate than patients who receive only tamoxifen.

3 Apr 2007

Triple negative breast cancers more common among women who are African American and Hispanic, under 40 years old

So-called "triple negative" breast cancers, tumors that do not contain any of three significant tumor markers, are aggressive, deadly cancers that affect young, poor minority women, according to a new study.

2 Apr 2007

Estrogen improves host response after traumatic injury

Researchers have identified the receptor pathway used by estrogen to decrease liver injury after trauma and hemorrhage.

2 Apr 2007

Study describes how estradiol helps to maintain bone density

Researchers at the University at Buffalo have described a novel pathway by which estradiol, the primary estrogen in humans, aids in maintaining bone density, a function critical to avoiding osteoporosis.

25 Mar 2007

Large-scale Japanese study finds soy protective against localized prostate cancer, but not advanced

The largest study examining the relationship between the traditional soy-rich Japanese diet and development of prostate cancer in Japanese men has come to a seemingly contradictory conclusion: intake of isoflavone chemicals, derived largely from soy foods, decreased the risk of localized prostate cancer but increased the risk of advanced prostate cancer.

15 Mar 2007

Study aims to find which breast cancer patients need chemotherapy

Most postmenopausal women with small breast tumors don't need chemotherapy to reduce their recurrence risk after lumpectomy.

13 Mar 2007

Australian researcher unveils pregnancy mystery

Belinda Hardman completed the study for her PhD with Deakin's Centre for Cellular and Molecular Biology under the supervision of Dr Leigh Ackland.

5 Mar 2007

Osteopenia and cancer in children and adolescents

Physicians caring for children with cancer should be on the lookout for signs of bone fragility caused by disease and treatment, according to a new report.

26 Feb 2007

Hormone patch could be safer than pills in relieving the symptoms of the menopause

According to new research by French scientists hormone skin patches and gels are far less likely than pills to cause dangerous blood clots.

26 Feb 2007

Natural family planning as effective as the pill

According to the latest research a system of natural family planning is just as effective as the contraceptive pill.

22 Feb 2007

A black and white look at breast cancer mortality

African and African American women are more likely to die of breast cancer than their white counterparts because they tend to get the disease before the menopause, suggests new research from the University of East Anglia and the Children’s Hospital Boston in collaboration with researchers in the U.S. and Italy.

21 Feb 2007

Health care professionals should focus on women's lifetime heart disease risk

The 2007 Guidelines for Preventing Cardiovascular Disease in Women -- published today in a special women's health issue of Circulation: Journal of the American Heart Association -- also include new directions for using aspirin, hormone therapy and vitamin and mineral supplements in heart disease and stroke prevention in women.

20 Feb 2007

Tamoxifen offers long-term benefits for breast cancer prevention among women at high risk

The trials found that the breast cancer risk reduction persists long after women stop taking tamoxifen.

20 Feb 2007

Researchers discover markers that identify breast cancer subtypes resistant to Herceptin

Using gene chips to profile tumors before treatment, researchers at Harvard and Yale Universities found markers that identified breast cancer subtypes resistant to Herceptin, the primary treatment for HER2-positive breast cancer. They say this advance could help further refine therapy for the 25 to 30 percent of breast cancer patients with this class of tumor.

20 Feb 2007

An aspirin a day keeps heart disease away

According to new guidelines released by the American Heart Association, almost all women are at risk of heart disease and doctors should consider prescribing a daily aspirin for them.

20 Feb 2007

Updated guidelines provide definitive answers on HRT, aspirin, supplements

Health care professionals should focus on women's lifetime heart disease risk, not just short-term risk, according to updated American Heart Association guidelines.

20 Feb 2007

Active lifestyle reduces risk of invasive breast cancer

Six or more hours per week of strenuous recreational activity may reduce the risks of invasive breast cancer by 23 percent, according to researchers from the University of Wisconsin Paul P. Carbone Comprehensive Cancer Center (UWCCC).

15 Feb 2007

New breast cancer drug Exemestane shows great potential to save lives

In what will be welcome news to millions of women suffering from breast cancer, trials of a new drug have found it lowers oestrogen levels in women with hormone-sensitive breast cancer and has the potential to save more than 1,000 lives a year in the UK alone.

13 Feb 2007

Switching treatment to exemestane after 2-3 years on tamoxifen, improves survival

The Intergroup Exemestane Study (IES), an extensive, international study, tested the superiority of switching to exemestane (an aromatase inhibitor) from tamoxifen in patients with early breast cancer.

13 Feb 2007

Estrogen News and Research

Latest Estrogen News and Research

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause

Chemotherapy and tamoxifen combination improves survival for early-stage breast cancer patients

Triple negative breast cancers more common among women who are African American and Hispanic, under 40 years old

Estrogen improves host response after traumatic injury

Study describes how estradiol helps to maintain bone density

Large-scale Japanese study finds soy protective against localized prostate cancer, but not advanced

Study aims to find which breast cancer patients need chemotherapy

Australian researcher unveils pregnancy mystery

Osteopenia and cancer in children and adolescents

Hormone patch could be safer than pills in relieving the symptoms of the menopause

Natural family planning as effective as the pill

A black and white look at breast cancer mortality

Health care professionals should focus on women's lifetime heart disease risk

Tamoxifen offers long-term benefits for breast cancer prevention among women at high risk

Researchers discover markers that identify breast cancer subtypes resistant to Herceptin

An aspirin a day keeps heart disease away

Updated guidelines provide definitive answers on HRT, aspirin, supplements

Active lifestyle reduces risk of invasive breast cancer

New breast cancer drug Exemestane shows great potential to save lives

Switching treatment to exemestane after 2-3 years on tamoxifen, improves survival

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Estrogen News and Research

Latest Estrogen News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in